Contemporary role of androgen deprivation therapy for prostate cancer.

  title={Contemporary role of androgen deprivation therapy for prostate cancer.},
  author={Vincenzo Pagliarulo and Sergio Bracarda and Mario A. Eisenberger and Nicolas Mottet and Fritz H. Schroeder and Cora N Sternberg and Urs E Studer},
  journal={European urology},
  volume={61 1},
CONTEXT Androgen deprivation therapy (ADT) for prostate cancer (PCa) represents one of the most effective systemic palliative treatments known for solid tumors. Although clinical trials have assessed the role of ADT in patients with metastatic and advanced locoregional disease, the risk-benefit ratio, especially in earlier stages, remains poorly defined. Given the mounting evidence for potentially life-threatening adverse effects with short- and long-term ADT, it is important to redefine the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS